Vedolizumab in paediatric IBD: a huge step forward but not there yet

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	3-5
Number of pages	3
Journal	The Lancet Gastroenterology and Hepatology
Volume	8
Issue number	1
DOIs	https://doi.org/10.1016/S2468-1253(22)00390-9
Publication status	Published - 1 Jan 2023

Access to Document

@article{13df389c59b34c45a9a5021aa311026a,

title = "Vedolizumab in paediatric IBD: a huge step forward but not there yet",

author = "Klomberg, {Renz C.W.} and {de Ridder}, Lissy",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/S2468-1253(22)00390-9",

language = "English",

volume = "8",

pages = "3--5",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd.",

number = "1",

}

TY - JOUR

T1 - Vedolizumab in paediatric IBD

T2 - a huge step forward but not there yet

AU - Klomberg, Renz C.W.

AU - de Ridder, Lissy

PY - 2023/1/1

Y1 - 2023/1/1

UR - http://www.scopus.com/inward/record.url?scp=85143917621&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(22)00390-9

DO - 10.1016/S2468-1253(22)00390-9

M3 - Comment/Letter to the editor

C2 - 36495909

AN - SCOPUS:85143917621

VL - 8

SP - 3

EP - 5

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

SN - 2468-1253

IS - 1

ER -